Advertisement

Inpharma Weekly

, Volume 1570, Issue 1, pp 18–18 | Cite as

Mifepristone provides clear QOL benefit in uterine leiomyoma

Clinical study
  • 4 Downloads

Keywords

Placebo Recipient Leiomyoma Study Endpoint Mifepristone Uterine Fibroid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2007

Personalised recommendations